CLEVELAND, Oct. 3, 2017 /PRNewswire/ -- The results are in and GanedenBC30®, Ganeden's patented and shelf-stable probiotic strain, has been announced as the winner of the first annual IFT FoodTech Summit Innovation Award. The award was developed by the Institute of Food Technologists (IFT) and Encumex to acknowledge innovation in the food science industry. IFT, in partnership with the Food Technology Summit & Expo, held an award ceremony on September 27 during the show in Mexico City to announce the winner and honorable mentions.
A panel of 6 highly qualified judges with a variety of backgrounds reviewed almost 40 entries that were submitted for the inaugural year, looking for the best examples of commercial innovation in the science of food. According to IFT, entries were judged based on degree of innovation, technological advancement, and benefits to both food manufacturers and consumers. The panel unanimously selected GanedenBC30 (Bacillus coagulans GBI-30, 6086), celebrating it as a breakthrough ingredient that answers the growing consumer demand for food and beverage products with enhanced health benefits and natural ingredients.
"On behalf of IFT, I'd like to congratulate Ganeden on winning the inaugural IFT FoodTech Summit Innovation Award," said IFT CEO Christie Tarantino-Dean, FASAE, CAE. "We received an overwhelming number of entries, and our distinguished panel of six jurors from academia and industry determined GanedenBC30 was the clear winner, and that the product represents a major advancement in probiotic fortification. We would like to commend Ganeden on the success of GanedenBC30 and are excited to see more innovations from the company in the future."
GanedenBC30 is the leading shelf-stable probiotic strain around the world, and has been formulated into more than 750 foods, beverages and companion animal products globally. It is best known for its spore-forming characteristics that allow it to remain stable enough for use in almost any food or beverage application, including processes where probiotics were unable to survive previously. The science-backed strain has opened up endless opportunities for probiotic fortification—moving the probiotic industry forward and allowing consumers to receive probiotic benefits in products that fit their daily routine and dietary preferences.
"Innovation is the driving factor behind all of the ingredients in our portfolio, and we are honored that the judges appreciated the major advancements that Ganeden has made in probiotic product development, regulatory work and science," said Michael Bush, president & CEO of Ganeden. "The stability of the GanedenBC30 strain provides a unique solution for both food manufacturers and consumers, leading the way for probiotic expansion far beyond the traditional formats of refrigerated products or supplements."
GanedenBC30 is approved in more than 68 countries and has had commercial availability in Mexico since 2016. For more information on the probiotic ingredient and Ganeden's other offerings, visit GanedenProbiotics.com.
About Ganeden:
Ganeden® is at the forefront of probiotic research and product development with an extensive library of published studies and more than 135 patents for probiotic technologies in the supplement, food, beverage, animal health, sports nutrition and personal care ingredients markets. Ganeden is best known for GanedenBC30® its patented, FDA GRAS and highly stable probiotic ingredient. Through the fermentation process of GanedenBC30, Ganeden developed Bonicel®, the first science-backed, probiotic-derived, personal care ingredient shown to dramatically reduce signs of aging. Ganeden's newest ingredient, Staimune™ is a patented probiotic technology comprising of inactivated GanedenBC30 cells, which have immune benefits. For more information about Ganeden and licensing opportunities, visit GanedenProbiotics.com.
About GanedenBC30:
GanedenBC30® (Bacillus coagulans GBI-30, 6086) is Ganeden's patented probiotic ingredient that can be found in more than 750 leading food, beverage, sports nutrition and companion animal products around the world. Unlike most other probiotic strains, GanedenBC30 is a spore-former which makes it highly stable and allows it to remain viable through most manufacturing processes, three years of shelf life and the low pH of stomach acid. The efficacy of GanedenBC30 is backed by over 27 published studies showing safety, digestive and immune support, and protein utilization benefits. GanedenBC30 has an exceptional safety record with FDA GRAS status from the United States FDA. It can be formulated into virtually any food, beverage or companion animal product that is baked, boiled, frozen or squeezed…. including all hot or refrigerated beverages. For more information, please visit GanedenBC30.com.
SOURCE Ganeden
Related Links
http://www.ganedenprobiotics.com
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article